JAK inhibitor BMS-066, Purity ≥98%

Cat. No.: X23-10-ZQ361

JAK inhibitor BMS-066, Purity ≥98%

Synonym: BMS-066; 914946-88-6; BL7XSD8R7B; N-((6-(1,6-Dihydro-1-methyl-4-(methylamino)imidazo(4,5-d)pyrrolo(2,3-b)pyridin-7-yl)-2-pyridinyl)methyl)-2-methoxyacetamide; JAK inhibitor

  • CAS Number: 914946-88-6
  • Compound CID: 24825710
Product Size
1 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
BMS-066 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets IKKβ and TYK2.
Molecular Weight
379.42
Molecular Formula
C19H21N7O2
Targets
IKKβ: 9 nM; TYK2: 72 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BMS-066 can be used to study its potential as a JAK2 inhibitor in various cancers and immune disorders.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.